• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PNPLA3 基因 patatin 样磷脂酶结构域包含 3 基因(PNPLA3)I148M 变体对非酒精性脂肪性肝病易感性和组织学严重程度影响的荟萃分析。

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.

机构信息

Department of Clinical and Molecular Hepatology, Institute of Medical Research A Lanari-IDIM, University of Buenos Aires-National-Council of Scientific and Technological Research (CONICET), Ciudad Autónoma de Buenos Aires, Argentina.

出版信息

Hepatology. 2011 Jun;53(6):1883-94. doi: 10.1002/hep.24283. Epub 2011 May 14.

DOI:10.1002/hep.24283
PMID:21381068
Abstract

UNLABELLED

Our objective was to estimate the strength of the effect of the I148M (rs738409 C/G) patatin-like phospholipase domain containing 3 (PNPLA3) variant on nonalcoholic fatty liver (NAFLD) and disease severity across different populations. We performed a systematic review by a meta-analysis; literature searches identified 16 studies. Our results showed that rs738409 exerted a strong influence not only on liver fat accumulation (GG homozygous showed 73% higher lipid fat content when compared with CC ones, data from 2,937 subjects; P < 1 × 10(-9) ), but also on the susceptibility of a more aggressive disease (GG homozygous had 3.24-fold greater risk of higher necroinflammatory scores and 3.2-fold greater risk of developing fibrosis when compared with CC homozygous; P < 1 × 10(-9) ; data from 1,739 and 2,251 individuals, respectively). Nonalcoholic steatohepatitis (NASH) was more frequently observed in GG than CC homozygous (odds ratio [OR] 3.488, 95% confidence interval [CI] 1.859-6.545, random model; P < 2 × 10(-4) ; data from 2,124 patients). Evaluation of the risk associated with heterozygosity for the variant suggests that the additive genetic model best explains the effect of rs738409 on the susceptibility to develop NAFLD. Nevertheless, carrying two G alleles does not seem to increase the risk of severe histological features. Meta-regression showed a negative correlation between male sex and the effect of rs738409 on liver fat content (slope: -2.45 ± 1.04; P < 0.02). The rs738409 GG genotype versus the CC genotype was associated with a 28% increase in serum alanine aminotransferase levels.

CONCLUSION

By summarizing the amount of evidence, this study provided unequivocal evidence of rs738409 as a strong modifier of the natural history of NAFLD in different populations around the world.

摘要

未标注

本研究旨在评估载脂蛋白样磷脂酶域包含 3(PNPLA3)基因 I148M(rs738409 C/G)变异对不同人群中非酒精性脂肪性肝病(NAFLD)和疾病严重程度的影响强度。我们进行了一项荟萃分析的系统综述;文献检索共确定了 16 项研究。我们的研究结果表明,rs738409 不仅对肝脂肪堆积有很强的影响(与 CC 纯合子相比,GG 纯合子的脂质脂肪含量高 73%,来自 2937 名受试者的数据;P < 1×10(-9)),而且对更具侵袭性疾病的易感性也有很强的影响(与 CC 纯合子相比,GG 纯合子发生更高的坏死性炎症评分和纤维化的风险分别增加 3.24 倍和 3.2 倍;P < 1×10(-9);来自 1739 名和 2251 名个体的数据)。与 CC 纯合子相比,GG 纯合子更常发生非酒精性脂肪性肝炎(NASH)(比值比[OR]3.488,95%置信区间[CI]1.859-6.545,随机模型;P < 2×10(-4);来自 2124 名患者的数据)。对该变异杂合子相关风险的评估表明,加性遗传模型最能解释 rs738409 对 NAFLD 易感性的影响。然而,携带两个 G 等位基因似乎不会增加严重组织学特征的风险。Meta 回归显示,男性性别与 rs738409 对肝脂肪含量的影响呈负相关(斜率:-2.45±1.04;P < 0.02)。与 CC 基因型相比,rs738409 GG 基因型与血清丙氨酸氨基转移酶水平升高 28%相关。

结论

通过总结证据量,本研究提供了明确的证据,表明 rs738409 是世界各地不同人群中 NAFLD 自然史的一个强有力的修饰因子。

相似文献

1
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.PNPLA3 基因 patatin 样磷脂酶结构域包含 3 基因(PNPLA3)I148M 变体对非酒精性脂肪性肝病易感性和组织学严重程度影响的荟萃分析。
Hepatology. 2011 Jun;53(6):1883-94. doi: 10.1002/hep.24283. Epub 2011 May 14.
2
Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.PNPLA3基因rs738409多态性与非酒精性脂肪性肝病(NAFLD)易感性及严重程度的关联:一项荟萃分析。
Medicine (Baltimore). 2019 Feb;98(7):e14324. doi: 10.1097/MD.0000000000014324.
3
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials.AZD2693,一种PNPLA3反义寡核苷酸,用于治疗148M纯合子参与者的MASH:两项随机I期试验。
J Hepatol. 2025 Jan 9. doi: 10.1016/j.jhep.2024.12.046.
4
Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.载脂蛋白基因多态性与儿童非酒精性脂肪性肝病的关系: 荟萃分析。
BMC Med Genet. 2020 Aug 18;21(1):163. doi: 10.1186/s12881-020-01098-8.
5
PNPLA3 and SAMM50 variants are associated with lean nonalcoholic fatty liver disease in Asian population.PNPLA3和SAMM50基因变异与亚洲人群的瘦型非酒精性脂肪性肝病相关。
Ann Hepatol. 2025 Jan-Jun;30(1):101761. doi: 10.1016/j.aohep.2024.101761. Epub 2024 Dec 3.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis.肥胖与非酒精性脂肪性肝病严重程度的关系:系统评价和荟萃分析。
Expert Rev Gastroenterol Hepatol. 2018 May;12(5):491-502. doi: 10.1080/17474124.2018.1460202. Epub 2018 Apr 2.
8
Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.载脂蛋白基因 3 上 rs738409 多态性与肝损伤及非酒精性脂肪性肝病的发生相关。
BMC Med Genet. 2010 Dec 22;11:172. doi: 10.1186/1471-2350-11-172.
9
I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.I148M 伴血小板型磷酸脂酶结构域包含 3 基因变异与儿科非酒精性脂肪性肝病严重程度的关系。
Hepatology. 2010 Oct;52(4):1274-80. doi: 10.1002/hep.23823.
10
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.载脂蛋白样磷脂酶 3/脂联素 I148M 基因多态性纯合子影响非酒精性脂肪性肝病患者的肝纤维化。
Hepatology. 2010 Apr;51(4):1209-17. doi: 10.1002/hep.23622.

引用本文的文献

1
Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver Biomarkers.代谢功能障碍相关脂肪性肝病(MASLD)患者的早期见解:一项关于多基因风险和肝脏生物标志物的观察性研究
Int J Mol Sci. 2025 Aug 29;26(17):8426. doi: 10.3390/ijms26178426.
2
Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: Pathophysiology, clinical implications, and emerging therapies.探索代谢功能障碍相关脂肪性肝病与肠道菌群失调之间的相互作用:病理生理学、临床意义及新兴疗法。
World J Hepatol. 2025 Aug 27;17(8):108730. doi: 10.4254/wjh.v17.i8.108730.
3
Genetic Risk of MASLD in Mongolians: Role of and SNPs.
蒙古族非酒精性脂肪性肝病的遗传风险: 及单核苷酸多态性的作用。
Curr Issues Mol Biol. 2025 Aug 1;47(8):605. doi: 10.3390/cimb47080605.
4
Fifteen Years of PNPLA3: Transforming Hepatology Through Human Genetics.PNPLA3的十五年:通过人类遗传学改变肝病学
Liver Int. 2025 Sep;45(9):e70240. doi: 10.1111/liv.70240.
5
Polymorphism's MBOAT7 as Risk and MTARC1 as Protection for Liver Fibrosis in MASLD.多态性的MBOAT7在代谢相关脂肪性肝病中作为肝纤维化的风险因素,而MTARC1则作为保护因素。
Int J Mol Sci. 2025 Jul 3;26(13):6406. doi: 10.3390/ijms26136406.
6
Integrated Patient Digital and Biomimetic Twins for Precision Medicine: A Perspective.用于精准医学的综合患者数字双胞胎和仿生双胞胎:一种观点
Semin Liver Dis. 2025 Jul 23. doi: 10.1055/a-2649-1560.
7
Deep Learning Reveals Liver MRI Features Associated With PNPLA3 I148M in Steatotic Liver Disease.深度学习揭示脂肪性肝病中与PNPLA3 I148M相关的肝脏MRI特征。
Liver Int. 2025 Jul;45(7):e70164. doi: 10.1111/liv.70164.
8
Psoriasis, metabolic syndrome and methotrexate: Is this association suitable for a new subcategory in steatotic liver disease?银屑病、代谢综合征与甲氨蝶呤:这种关联是否适用于脂肪性肝病中的一个新亚类?
World J Hepatol. 2025 Apr 27;17(4):102978. doi: 10.4254/wjh.v17.i4.102978.
9
Gene-based therapies for steatotic liver disease.基于基因的脂肪性肝病治疗方法。
Mol Ther. 2025 Jun 4;33(6):2527-2547. doi: 10.1016/j.ymthe.2025.04.024. Epub 2025 Apr 19.
10
Global burden trends and forecasts for MAFLD in adolescents and young adults from 1990 to 2021.1990年至2021年青少年和青年中MAFLD的全球负担趋势及预测
Sci Rep. 2025 Apr 19;15(1):13534. doi: 10.1038/s41598-025-98489-9.